Caplin Point Laboratories has announced the appointment of Ashok Partheeban and Vivek Partheeban as Additional Directors and Vice-Chairmen, effective November 5, 2025. Furthermore, Dr. K. C. John has been appointed as an Additional Director (Non-executive Independent) for a term of five years. These appointments are subject to shareholder approval and aim to bolster the company’s strategic direction and governance.
Leadership Expansion
Caplin Point Laboratories has expanded its leadership team with the appointment of two new Vice-Chairmen and an independent director. These appointments, effective November 5, 2025, aim to drive the company’s strategic goals and enhance its governance.
Key Appointments
Ashok Partheeban has been appointed as an Additional Director and Vice-Chairman. He previously served as Business Head – LATAM. His extensive experience in the pharmaceutical industry is expected to contribute significantly to the company’s growth.
Vivek Partheeban has been appointed as an Additional Director and Vice-Chairman. Formerly the COO, he has been instrumental in driving business growth, operational efficiency, and strategic expansion.
Dr. K. C. John has been appointed as an Additional Director (Non-executive Independent). His term is for five years. Dr. John’s expertise in technology, innovation, and entrepreneurship will provide valuable insights.
Director Backgrounds
Ashok Partheeban has spent over 20 years in the pharmaceutical industry, previously leading business and marketing operations across the LATAM region for Caplin Point Laboratories.
Vivek Partheeban, formerly the COO, also heads the company’s U.S. business operations and has held Directorships on the Board of other group Companies like Caplin Steriles Limited and Caplin One Labs Limited.
Dr. K. C. John has over 35 years of experience in technology, innovation, and entrepreneurship. He has held positions as educator, executive coach, and independent director in various companies.
Source: BSE
